MX337048B - Vacuna marcadora para la fiebre porcina clasica. - Google Patents
Vacuna marcadora para la fiebre porcina clasica.Info
- Publication number
- MX337048B MX337048B MX2012013419A MX2012013419A MX337048B MX 337048 B MX337048 B MX 337048B MX 2012013419 A MX2012013419 A MX 2012013419A MX 2012013419 A MX2012013419 A MX 2012013419A MX 337048 B MX337048 B MX 337048B
- Authority
- MX
- Mexico
- Prior art keywords
- swine fever
- classical swine
- marker vaccine
- relates
- marker
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención se refiere a una vacuna marcadora para el tratamiento profiláctico de la fiebre porcina clásica que comprende el virus vivo modificado atenuado de la fiebre porcina clásica. La secuencia viral de aminoácidos del epítope TAV de la proteína E2 comprende una secuencia diferente de la de un virus de tipo silvestre de la fiebre porcina clásica. La invención se refiere a composiciones farmacéuticas de la vacuna marcadora. La invención también se refiere a un procedimiento para fabricar las vacunas marcadoras para la prevención de la fiebre porcina clásica usando presión selectiva de anticuerpos.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10075206 | 2010-05-18 | ||
EP10075205 | 2010-05-18 | ||
DE102010017006 | 2010-05-18 | ||
EP10075207 | 2010-05-18 | ||
EP10075760 | 2010-12-17 | ||
EP10075759 | 2010-12-17 | ||
EP11159207 | 2011-03-22 | ||
PCT/EP2011/002624 WO2011144360A1 (en) | 2010-05-18 | 2011-05-18 | Marker vaccine for classical swine fever |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012013419A MX2012013419A (es) | 2013-01-28 |
MX337048B true MX337048B (es) | 2016-02-11 |
Family
ID=44461927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012013419A MX337048B (es) | 2010-05-18 | 2011-05-18 | Vacuna marcadora para la fiebre porcina clasica. |
Country Status (19)
Country | Link |
---|---|
US (1) | US9315873B2 (es) |
EP (1) | EP2571519B1 (es) |
KR (1) | KR101845571B1 (es) |
CN (1) | CN102905725B (es) |
BR (1) | BR112012029145B8 (es) |
CA (1) | CA2801897C (es) |
CY (1) | CY1118060T1 (es) |
DK (1) | DK2571519T3 (es) |
EA (1) | EA031518B1 (es) |
ES (1) | ES2593965T3 (es) |
HR (1) | HRP20161225T1 (es) |
HU (1) | HUE029385T2 (es) |
MX (1) | MX337048B (es) |
PL (1) | PL2571519T3 (es) |
PT (1) | PT2571519T (es) |
RS (1) | RS55214B1 (es) |
SI (1) | SI2571519T1 (es) |
WO (1) | WO2011144360A1 (es) |
ZA (1) | ZA201208194B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103159858B (zh) * | 2013-02-26 | 2014-06-04 | 中国农业科学院上海兽医研究所 | 猪瘟分支肽及其应用 |
DK3146042T3 (da) * | 2014-05-23 | 2019-09-30 | Boehringer Ingelheim Vetmedica Gmbh | Rekombinant klassisk svinepestvirus (CSFV) med substitution i E2-proteinets TAV-epitop |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995035380A1 (en) * | 1994-06-17 | 1995-12-28 | Instituut Voor Dierhouderij En Diergezondheid | Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
US8846055B2 (en) * | 2006-05-30 | 2014-09-30 | The United States Of America, As Represented By The Secretary Of Agriculture | Virulence determinant within the E2 structural glycoprotein of classical swine fever virus |
US8133495B2 (en) * | 2007-05-22 | 2012-03-13 | The United States Of America As Represented By The Secretary Of Agriculture | Live attenuated antigenically marked classical swine fever virus |
EP2202298A1 (en) * | 2008-12-23 | 2010-06-30 | Stichting Dienst Landbouwkundig Onderzoek | Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV |
-
2011
- 2011-05-18 PT PT117245480T patent/PT2571519T/pt unknown
- 2011-05-18 ES ES11724548.0T patent/ES2593965T3/es active Active
- 2011-05-18 EP EP11724548.0A patent/EP2571519B1/en active Active
- 2011-05-18 US US13/698,580 patent/US9315873B2/en active Active
- 2011-05-18 WO PCT/EP2011/002624 patent/WO2011144360A1/en active Application Filing
- 2011-05-18 CA CA2801897A patent/CA2801897C/en active Active
- 2011-05-18 BR BR112012029145A patent/BR112012029145B8/pt active IP Right Grant
- 2011-05-18 EA EA201270794A patent/EA031518B1/ru unknown
- 2011-05-18 MX MX2012013419A patent/MX337048B/es active IP Right Grant
- 2011-05-18 RS RS20160807A patent/RS55214B1/sr unknown
- 2011-05-18 CN CN201180024834.0A patent/CN102905725B/zh active Active
- 2011-05-18 PL PL11724548T patent/PL2571519T3/pl unknown
- 2011-05-18 SI SI201130975A patent/SI2571519T1/sl unknown
- 2011-05-18 DK DK11724548.0T patent/DK2571519T3/en active
- 2011-05-18 KR KR1020127032927A patent/KR101845571B1/ko active IP Right Grant
- 2011-05-18 HU HUE11724548A patent/HUE029385T2/en unknown
-
2012
- 2012-10-31 ZA ZA2012/08194A patent/ZA201208194B/en unknown
-
2016
- 2016-09-26 HR HRP20161225TT patent/HRP20161225T1/hr unknown
- 2016-09-27 CY CY20161100960T patent/CY1118060T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
BR112012029145B8 (pt) | 2022-03-08 |
BR112012029145B1 (pt) | 2021-09-14 |
WO2011144360A1 (en) | 2011-11-24 |
ES2593965T3 (es) | 2016-12-14 |
PL2571519T3 (pl) | 2017-07-31 |
EA031518B1 (ru) | 2019-01-31 |
EP2571519B1 (en) | 2016-06-29 |
US20130129762A1 (en) | 2013-05-23 |
KR20130109008A (ko) | 2013-10-07 |
HUE029385T2 (en) | 2017-02-28 |
DK2571519T3 (en) | 2016-10-17 |
US9315873B2 (en) | 2016-04-19 |
CN102905725B (zh) | 2016-01-20 |
MX2012013419A (es) | 2013-01-28 |
CA2801897A1 (en) | 2011-11-24 |
CA2801897C (en) | 2019-01-15 |
RS55214B1 (sr) | 2017-02-28 |
CY1118060T1 (el) | 2017-06-28 |
SI2571519T1 (sl) | 2017-01-31 |
HRP20161225T1 (hr) | 2016-12-02 |
EA201270794A1 (ru) | 2013-04-30 |
BR112012029145A2 (pt) | 2020-07-07 |
CN102905725A (zh) | 2013-01-30 |
PT2571519T (pt) | 2016-10-03 |
KR101845571B1 (ko) | 2018-04-04 |
ZA201208194B (en) | 2014-01-29 |
EA201270794A8 (ru) | 2017-10-31 |
EP2571519A1 (en) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20200091A1 (ar) | جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري | |
MX359954B (es) | Ácido nucleico que comprende o codifica para un asa troncal de histona y una secuencia poly (a) o una señal de poliadenilación para aumentar la expresión de un antígeno patogénico codificado. | |
MX369469B (es) | Vacuna contra el virus respiratorio sincitial. | |
WO2012027365A3 (en) | Targeted multi-epitope dosage forms for induction of an immune response to antigens | |
EA201270063A1 (ru) | Рекомбинантные антигены pcb | |
AU2014310935B2 (en) | Combination vaccine | |
WO2007095318A3 (en) | Influenza antigens, vaccine compositions, and related methods | |
EA201391515A1 (ru) | Инактивированная вакцина вируса денге | |
BR112013011194A2 (pt) | partículas de glicoproteína semelhantes a vírus (vlps) da raiva. | |
WO2013106834A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
MX352478B (es) | Proteina vp6 de la capside de norovirus y rotavirus para el uso como vacuna combinada. | |
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
MX344103B (es) | Vacunas de virus herpes vectorizado con virus de enfermedad de newcastle. | |
WO2014150822A3 (en) | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use | |
MY179251A (en) | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | |
AU2014232363A8 (en) | Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom | |
MX2019007252A (es) | Metodos y composiciones para vacunas del virus del dengue. | |
PH12017501100A1 (en) | Recombinant swinepox virus and vaccines | |
EA201500140A1 (ru) | Ослабленные вакцины от свиного гриппа и способы их получения и применения | |
IN2014DN09445A (es) | ||
MX2019007924A (es) | Vacunas contra la influenza. | |
MX337048B (es) | Vacuna marcadora para la fiebre porcina clasica. | |
IN2014DN07152A (es) | ||
MX2013009310A (es) | Terapeuticos a base de levadura para infeccion de la hepatitis b cronica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |